Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Insider Sold Shares Worth $4,855,312, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $4,855,312, According to a Recent SEC Filing

MT newswireMT newswire2026/09/01 20:40
04:40 PM EDT, 09/01/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on August 31, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $4,855,312. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000132/xslF345X05/primarydocument.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Sector Update: Financial

MT newswire•2026/09/25 13:05

Musk stated: The Nvidia chips deployed for Colossus 2 may double by the end of the year

Elon Musk stated that his AI computing cluster Colossus 2 has now deployed 110,000 Nvidia GB200 chips and 440,000 GB300 chips, totaling 550,000 chips. By the end of the year, the number of chips may exceed double the current amount.

华尔街见闻•2026/09/25 12:51
Musk stated: The Nvidia chips deployed for Colossus 2 may double by the end of the year